NEENA MATHEWS: Open Payments
NPI 1013419621 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 64 payments from 13 companies in 2025. Trend: 2023 $1,655 · 2024 $1,160 · 2025 $1,482
Food & beverage: $1,338Education: $144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $370 |
| Amgen Inc. | 19 | $323 |
| Janssen Biotech, Inc. | 9 | $272 |
| UCB, Inc. | 7 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| PFIZER INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Organon LLC | 2 | $29 |
Products named: RINVOQ, TREMFYA, KRYSTEXXA, Bimzelx, SAPHNELO, SKYRIZI, TAVNEOS, ORENCIA.
Industry payments across TX — which companies pay providers there.
